Skip to main content
logo
Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
134.99
+1.84 (1.38%)
At close: Oct 31, 2025, 4:00 PM EST
134.50
-0.49 (-0.36%)
Pre-market: Nov 3, 2025, 7:13 AM EST

Axsome Therapeutics Revenue

Axsome Therapeutics had revenue of $150.04M in the quarter ending June 30, 2025, with 72.13% growth. This brings the company's revenue in the last twelve months to $495.03M, up 69.83% year-over-year. In the year 2024, Axsome Therapeutics had annual revenue of $385.69M with 42.53% growth.

Revenue (ttm)
$495.03M
Revenue Growth
+69.83%
P/S Ratio
13.29
Revenue / Employee
$724,792
Employees
683
Market Cap
6.74B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024385.69M115.09M42.53%
Dec 31, 2023270.60M220.56M440.80%
Dec 31, 202250.04M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca56.50B
Novartis AG56.37B
Novo Nordisk49.11B
Revenue Rankings

AXSM News

More News